- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01997216
Multifocal Lens Design Evaluation
December 17, 2013 updated by: Alcon Research
Multifocal Lens Design Evaluation (US)
The purpose of this study was to compare binocular high contrast, high illumination (HC/HI) visual acuity at near (40 centimeters) of new multifocal contact lenses against AIR OPTIX® AQUA MULTIFOCAL contact lenses when worn for 9 hours.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Each participant was randomized to a specific sequence of lens wear, during which each lens type was worn bilaterally for 9 hours to compare performance characteristics.
Study Type
Interventional
Enrollment (Actual)
42
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Sign written Informed Consent document.
- Have spectacles that provide acceptable vision and be willing to wear them if unable to wear the study lenses.
- Be presbyopic with a spectacle add ≥ 0.50 diopter.
- Currently wearing soft contact lenses at least 5 days a week.
- Other protocol-specified inclusion criteria may apply
Exclusion Criteria:
- Eye injury or surgery within 12 weeks of enrollment in this trial.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Currently enrolled in any clinical trial.
- Evidence of systemic or ocular abnormality, infection, or disease which is likely to affect successful wear of contact lenses (for at least 9 hours) or use of their accessory solutions as determined by the Investigator.
- Any use of medications for which contact lens wear could be contraindicated as determined by the Investigator.
- Binocular visual acuity worse than 20/25.
- Corrected by monovision.
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Delefilcon A MF, then AOAMF
Delefilcon A multifocal contact lenses, followed by lotrafilcon B multifocal contact lenses, as randomized.
Each product was worn bilaterally (in both eyes) for 9 hours.
The wear periods were separated by 2 ± 1 days.
|
Investigational silicone hydrogel contact lens dispensed in low, medium, or high ADD per current AIR OPTIX® AQUA MULTIFOCAL fitting guidelines
Commercially marketed silicone hydrogel contact lens dispensed in low, medium, or high ADD per current AIR OPTIX® AQUA MULTIFOCAL fitting guidelines
Other Names:
|
Other: AOAMF, then Delefilcon A MF
Lotrafilcon B multifocal contact lenses, followed by delefilcon A multifocal contact lenses, as randomized.
Each product was worn bilaterally (in both eyes) for 9 hours.
The wear periods were separated by 2 ± 1 days.
|
Investigational silicone hydrogel contact lens dispensed in low, medium, or high ADD per current AIR OPTIX® AQUA MULTIFOCAL fitting guidelines
Commercially marketed silicone hydrogel contact lens dispensed in low, medium, or high ADD per current AIR OPTIX® AQUA MULTIFOCAL fitting guidelines
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Binocular HC/HI Visual Acuity at Near (40 cm)
Time Frame: Up to Hour 9
|
The participant read a Snellen chart at 40 centimeters with both eyes together while wearing study lenses.
The Snellen acuity was converted into logMAR units (logarithm of the minimum angle of resolution).
A 20/20 Snellen acuity equates to a logMAR acuity of 0.0 and is considered normal near eyesight.
A negative logMAR value denotes better visual acuity.
|
Up to Hour 9
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Binocular HC/HI Visual Acuity at Distance
Time Frame: Up to Hour 9
|
The participant read a Snellen chart at a 20-foot equivalent distance with both eyes together while wearing study lenses.
The Snellen acuity was converted into logMAR units (logarithm of the minimum angle of resolution).
A 20/20 Snellen acuity equates to a logMAR acuity of 0.0 and is considered normal distance eyesight.
A negative logMAR value denotes better visual acuity.
|
Up to Hour 9
|
Mean Monocular Over-refraction (OR) at Distance
Time Frame: Up to Hour 9
|
OR is the amount of additional correction needed to improve visual acuity (VA).
The OR at dispense was conducted with non-study product to determine lens power for the 9-hour wear.
Dispensing of the study product (Pair 1 and Pair 2) was dependent upon lens power as determined by OR and resultant product availability.
The OR at 9 hours was conducted with study product.
All OR data is reported regardless whether study product was dispensed.
Each eye contributed to the mean.
|
Up to Hour 9
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Joachim Nick, Dipl.-Ing, Alcon Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2012
Primary Completion (Actual)
November 1, 2012
Study Completion (Actual)
November 1, 2012
Study Registration Dates
First Submitted
November 19, 2013
First Submitted That Met QC Criteria
November 22, 2013
First Posted (Estimate)
November 28, 2013
Study Record Updates
Last Update Posted (Estimate)
February 4, 2014
Last Update Submitted That Met QC Criteria
December 17, 2013
Last Verified
December 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- C-12-036
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Error
-
Alcon ResearchCompletedRefractive Error - Myopia Severe | Refractive Error - Myopia SimpleUnited States, Ireland, Singapore
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Wang HongxiaTianjin Eye HospitalCompletedRefractive Error - Myopia AxialChina
-
Tianjin Eye HospitalRecruitingMyopia; Refractive ErrorChina
-
Abbott Medical OpticsCompletedStable Myopic Refractive Error, With or Without AstigmatismUnited States
-
KK Women's and Children's HospitalWithdrawnRefractive Error - Myopia
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
Clinical Trials on Delefilcon A multifocal contact lens
-
Johnson & Johnson Vision Care, Inc.Completed
-
Alcon ResearchCompletedRefractive Error | Astigmatism | Myopia
-
Alcon, a Novartis CompanyCompletedRefractive ErrorUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Alcon, a Novartis CompanyCompletedRefractive Error
-
University of HoustonCompleted
-
CIBA VISIONCompleted
-
Coopervision, Inc.CORECompletedPresbyopiaUnited States, Canada